- Home
- BABA vs ABBV Comparison
BABA vs ABBV Comparison
Compare BABA & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BABA
- ABBV
- Stock Information
- Founded
- BABA 1999
- ABBV 2012
- Country
- BABA Hong Kong
- ABBV United States
- Employees
- BABA N/A
- ABBV N/A
- Industry
- BABA Business Services
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- BABA Consumer Discretionary
- ABBV Health Care
- Exchange
- BABA Nasdaq
- ABBV Nasdaq
- Market Cap
- BABA 423.5B
- ABBV 365.1B
- IPO Year
- BABA 2014
- ABBV N/A
- Fundamental
- Price
- BABA $167.24
- ABBV $229.01
- Analyst Decision
- BABA Strong Buy
- ABBV Buy
- Analyst Count
- BABA 13
- ABBV 22
- Target Price
- BABA $187.31
- ABBV $232.05
- AVG Volume (30 Days)
- BABA 21.1M
- ABBV 6.4M
- Earning Date
- BABA 11-14-2025
- ABBV 10-31-2025
- Dividend Yield
- BABA 0.63%
- ABBV 2.86%
- EPS Growth
- BABA 123.36
- ABBV N/A
- EPS
- BABA 8.62
- ABBV 2.10
- Revenue
- BABA $139,697,227,719.00
- ABBV $58,328,000,000.00
- Revenue This Year
- BABA $6.18
- ABBV $9.85
- Revenue Next Year
- BABA $11.31
- ABBV $8.98
- P/E Ratio
- BABA $19.38
- ABBV $109.31
- Revenue Growth
- BABA 5.32
- ABBV 6.05
- 52 Week Low
- BABA $80.06
- ABBV $163.81
- 52 Week High
- BABA $192.67
- ABBV $244.81
- Technical
- Relative Strength Index (RSI)
- BABA 51.47
- ABBV 56.12
- Support Level
- BABA $160.00
- ABBV $225.32
- Resistance Level
- BABA $192.67
- ABBV $234.68
- Average True Range (ATR)
- BABA 5.83
- ABBV 5.30
- MACD
- BABA -3.34
- ABBV -1.26
- Stochastic Oscillator
- BABA 28.19
- ABBV 27.39
About BABA Alibaba Group Holding Limited
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China retail e-commerce platform is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China wholesale e-commerce, international retail and wholesale e-commerce, local consumer services, travel services, cloud computing, digital media and entertainment, Cainiao logistics services, and other businesses.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).